ICS 2011 Scientific Podium Poster Session S8 - Investigation and Intervention

	Wednesday 31st August 2011
	16:00 - 17:30
	Hall P2

16:30

#87 RANDOMIZED TRIAL COMPARING OUTPATIENT FLEXIBLE TO RIGID CYSTOSCOPY IN FEMALES

Presenter: Lieschen Quiroz

Quiroz L¹, Shobeiri S A¹, Nihira M¹, Brady J¹, Wild R¹
1. The University of Oklahoma HSC

16:35

#88 Relationship between bacteriuria and ATP concentrations in voided urodynamic fluid: a 2-year prospective study.

Presenter: Ying Cheng

Cheng Y¹, Walsh C¹, Mansfield K², Allen W¹, Moore K¹
1. St George Hospital, University of New South Wales, 2. University of Wollongong

16:40

#89 Inhibition of Urothelial TRPA1 Channels Protects the Bladder Against Radiation Cystitis.

Presenter: Irina Zabbarova

Zabbarova I¹, Wolf-Johnston A¹, Epperly M¹, Ikeda Y¹, Birder L¹, de Groat W¹, Freeman B¹, Kanai A¹
1. University of Pittsburgh

16:45

#90 Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicenter, double-blind, randomised, placebo controlled study.

Presenter: Pierre Denys

Denys P¹, Lenormand L², Costa P³, Chartier-Kastler E⁴, Grise P⁵, Hermieu J⁶, Amarenco G⁷, Karsenty G⁸, Saussine C⁹, Barbot F¹⁰
1. Hôpital Raymond Poincaré. Faculté de Médecine Paris Ile de France Ouest, 2. Hotel Dieu University Hospital, Nantes, France, 3. Service d'Urologie. CHU Nimes, 4. Service d'Urologie. Hôpital de la Pitié. Paris, 5. Service d'Urologie. CHU Rouen, 6. Service d'Urologie. Hopital Bichat. Paris, 7. Service de MPR. Hopital Tenon. Paris, 8. Service d'Urologie. CHU Marseille, 9. Service d'Urologie. CHU Strasbourg, 10. CIC Hopital Raymond Poincaré Garches

16:50

#91 A Dose-Exploration Study Of The Efficacy and Safety Of OnabotulinumtoxinA in Patients With Urinary Incontinence Due To Neurogenic Detrusor Overactivity

Presenter: Apostolos Apostolidis

Apostolidis A¹, Mourad S², Thompson C³, Yan X³, Haag-Molkenteller C³
1. Papageorgiou General Hospital, 2. Ain-Shams University, 3. Allergan, Inc.

16:55

#92 Efficacy and tolerability of once-daily mirabegron, a potent and selective ß3-adrenoceptor agonist, in patients with overactive bladder – results from a North American Phase III trial

Presenter: Victor Nitti

Nitti V¹, Herschorn S², Lee M³, Martin N⁴
1. NYU Langone Medical Center, Department of Urology, New York, NY, USA, 2. University of Toronto, Division of Urology, Toronto, Canada, 3. Astellas Pharma Global Development, Inc., Biostatistics, Deerfield, IL, USA, 4. Astellas Pharma Global Development, Inc., Global Medical Sciences, Deerfield, IL, USA

17:00

#93 Safety and Potential Effectiveness of Cook MyoSite Autologous Muscle Derived Cells for Treatment of Stress Urinary Incontinence: Preliminary Results from a Dose Escalation Study

Presenter: Melissa Kaufman

Kaufman M¹, Dmochowski R¹, Peters K², Carr L³, Herschorn S³, Fischer M², Sirls L², Biller D¹, Chancellor M²
1. Vanderbilt University Medical Center, 2. William Beaumont Hospital, 3. Sunnybrook Health Sciences Centre

17:05

#94 Brain activity underlying continence control in older women with urgency incontinence – a potential marker of functional status.

Presenter: Stasa Tadic

Tadic S¹, Griffiths D¹, Schaefer W¹, Clarkson B¹, Murrin A¹, Resnick N¹
1. University of Pittsburgh, Department of Medicine, Division of Geriatrics

17:10

#95 The physiological properties of the decompensated, spinal cord injured bladder

Presenter: John Young

Young J¹, Johnston L², McMurray G³, Eccles R³, McCloskey K², Fry C¹
1. University of Surrey, 2. Queen's University, Belfast, 3. Pfizer R&D, Sandwich, Kent

17:15

#96 An implantable pressure sensor to detect the onset of urinary bladder contractions

Presenter: Jacob Melgaard

Melgaard J¹, Rijkhoff N J M¹
1. Center for Sensory-Motor Interaction (SMI), Aalborg University

17:20

#97 Evaluation of a novel, non-invasive, patient-managed neuromodulation system (PMNS) on urgency urinary incontinence and patient-reported outcomes in subjects with overactive bladder (OAB) syndrome who had previously failed therapy: a four-week, multicenter, prospective randomized trial

Presenter: Roger Dmochowski

Monga A¹, Dmochowski R², Miller D³
1. Southampton University Hospital Trust, 2. Vanderbilt University Medical Center, 3. Wheaton Franciscan Healthcare

17:25

#98 DUAL VAGINAL VAULT SUPPORT AT COLPORRHAPHY - AN ANATOMICAL BASIS FOR A FOUR-PART VAGINAL REPAIR

Presenter: Bernard Haylen

Haylen B¹, Vu D², Stas V³, Tse K¹
1. University of New South Wales, Sydney. Australia., 2. University of New South Wales, Sydney. Australia, 3. St Vincent's Hospital, Sydney. Australia

Content Visitors (staff only)

Investigation and Intervention

Scientific Podium Poster Session S8

Session Schedule

Comments

Chat